BOSTON -- Beth Israel Deaconess Medical Center (BIDMC) and Alveolus, Inc., have announced the establishment of a program to pursue research and physician education in the field of interventional pulmonology. Based at BIDMC, the program will be headed by Armin Ernst, MD, Director of Interventional Pulmonology and Critical Care Medicine and a nationally renowned expert on central airway obstruction.

"This new endeavor will help advance technology and patient-care techniques in this growing area of medicine," says Ernst, who is also an Assistant Professor of Medicine at Harvard Medical School. The program will support both basic and clinical research in the field of Interventional Pulmonology and also calls for the creation of a course to instruct interventional pulmonologists in the use of stents for the treatment of central airway obstruction, a narrowing or collapse of the lungs' central airways that can develop as the result of cancers involving the trachea or central airway as well as any number of benign pulmonary disorders. Without immediate treatment, central airway obstruction can rapidly lead to disabling dyspnea, obstructive pneumonia, and impending suffocation.

"This is the first of what we hope will be a number of such initiatives," explains Eric Mangiardi, President of Alveolus, a Charlotte, North Carolina-based medical device company that specializes in the development of non-vascular interventional stents. "We selected BIDMC as the location of our inaugural program based on the medical center's longstanding commitment to advancing research and education in interventional pulmonology."

'"/>


9-Sep-2003

Page: 1
Related medicine news :

1. US cancer researchers launch first American-Israeli cancer conference
2. Unrestricted metabolic research grant awarded to Beth Israel Deaconess
3. Joslin and Beth Israel Deaconess Medical Center sign new joint venture clinical agreement
4. Beth Israel Deaconess study documents outstanding surgical outcomes for diabetes patients
5. William Cohn, M.D., of Beth Israel Deaconess Medical Center, receives the 2000 Distinguished Inventor Award
6. Medically supervised drug injection facilities safer for users
7. Medical molecules designed to respond to visible light that can penetrate tissue
8. Philanthropist Paul F. Glenn launches labs for aging research at Harvard Medical School
9. UCLA Medical Center becomes first hospital to introduce remote presence robots in ICU
10. New data on Orqis Medicals Cancion CRS to be reported at ACC
11. Medical technologies may hinder rather than help newborn survival